BEHANDLUNG VON KACHEXIE

European patent · EP2750709 · In force

Register entry

Publication number
EP2750709
Application number
EP12834301
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 21, 2012
Published
Jul 9, 2014
Granted
Aug 15, 2018
Protection ends at the latest
Sep 20, 2032
Next annual fee due
Sep 30, 2027
IPC classes
A61K 39/395 (2006.01)
A61K 38/20 (2006.01)
A61P 35/00 (2006.01)
A61P 31/06 (2006.01)
A61K 39/00 (2006.01)
C07K 16/24 (2006.01)
Priority
US 201161538309 P 23.09.2011
PCT application
PCT/US2012/056492 21.09.2012
PCT publication
WO2013/043973 28.03.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Jan 19, 2024

    Corrected

    Owner
    XBiotech, Inc., 1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada → XBiotech Inc., 1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada

    Published in Swissreg on 19.01.2024

  5. Jan 18, 2024

    Corrected

    Owner
    XBiotech, Inc, 1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada → XBiotech, Inc., 1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada

    Published in Swissreg on 18.01.2024

  6. Jan 17, 2024

    Transferred

    Owner
    Janssen Biotech, Inc., 800/850 Ridgeview Drive, Horsham, PA 19044, USA → XBiotech, Inc, 1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9, Canada

    Published in Swissreg on 17.01.2024

  7. Dec 20, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 20.12.2023

  8. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

4 earlier entries
  1. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  2. Dec 2, 2020

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 02.12.2020

  3. Dec 2, 2020

    Transferred

    Owner
    XBiotech, Inc, 1055 West Hastings Street, Suite 300, Vancouver, BC V6E 2E9, Canada → Janssen Biotech, Inc., 800/850 Ridgeview Drive, Horsham, PA 19044, USA

    Published in Swissreg on 02.12.2020

  4. Aug 15, 2018

    Granted

    Published in Swissreg on 15.08.2018

Parties

Holder

XBiotech Inc.

1055 West Hastings Street Suite 300, Vancouver, British Columbia V6E 2E9, CA

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

SIMARD,John

Austin, TX 78744, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.